Available in 1mg lyophilized vials
Science 335, 12381242
The five classifications are: Class 1: enzyme deficiency with chronic nonspherocytic hemolytic anemia Class 2: severe enzyme deficiency, less than 10% of normal activity Class 3: moderate to mild enzyme deficiency, 10-60% of normal activity Class 4: very mild or no enzyme deficiency, at least 60% of normal activity Class 5: increased enzyme activity Pathogenic variants in the G6PD gene that result in non-spherocytic hemolytic anemia have all been found to cluster near the carboxy terminal end of the protein, whereas, the pathogenic variants that result in clinically mild symptoms are clustered near the amino terminal end of the protein
Or do you think its a function of the concussion, the recovery from it, and the diminishing capacity of the body because it had to recover from that traumatic injury
In a confirmatory Phase III trial comparing Elahere to investigators choice of chemotherapy, AbbVies drug cut the risk of death by 33% and reduced the likelihood of cancer progression by 35%, the company reported
Supports broad-spectrum tissue repair & collagen support